Neuropsychiatric aspects of Huntington's disease

Journal of Neurology Neurosurgery and Psychiatry

Volumn 71, Issue 3, 2001, Pages 310-314

  Paulsen, J S ^a,b   Ready, R E ^b   Hamilton, J M ^c,d   Mega, M S ^e   Cummings, J L ^e  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d SAN DIEGO STATE UNIVERSITY   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Dementia; Huntington's disease; Neuropsychiatry

Indexed keywords

ADULT; AGED; AGITATION; ANXIETY; APATHY; ARTICLE; CAREGIVER; COGNITIVE DEFECT; CONTROLLED STUDY; DYSPHORIA; FEMALE; HUMAN; HUNTINGTON CHOREA; IRRITABILITY; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MOTOR DYSFUNCTION; NEUROPSYCHIATRY; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; SYMPTOM;

EID: 0034881096     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.71.3.310     Document Type: Article

References (30)

1. Caine ED, Shoulson I. Psychiatric syndromes in Huntington's disease. Am J Psychiatry 1983;140:728-33.
2. Cummings JL. Behavioral and psychiatric symptoms associated with Huntington's disease. In: Weiner WJ, Lang AE, eds. Behavioral neurology of movements disorders. New York: Raven Press, 1995:179-86.
3. Folstein SE, Folstein MF. Psychiatric features of Huntington's disease: recent approaches and findings [review]. Psychiatric Development 1983;1:193-205.
4. Shiwach R. Psychopathology in Huntington's disease patients. Acta Psychiatr Scand 1994;90:241-6.
5. Morris M. Psychiatric aspects of Huntington's disease: In: Harper PS, ed. Huntington's disease. London: WB Saunders, 1991:22:81-126.
6. Dewhurst K, Oliver JE, McKnight AL. Socio-psychiatric consequences of Huntington's disease. Br J Psychiatry 1970;116:255-8.
7. Gutekunst C, Li S, Yi H, et al. Nuclear and neuropil aggregates in Huntington's disease: relationship to neuropathology. J Neurosci 1999;19:2522-34.
8. Cha JH, Kosinski CM, Kerner JA, et al. Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human Huntington disease gene. Proc Natl Acad Sci USA 1998;95:6480-5.
9. Nauta WJ, Mehler WR. Projections of the lentiform nucleus in the monkey. Brain Res 1966;1:3-42.
10. Swerdlow NR, Koob GF. Lesions of the dorsomedial nucleus of the thalamus, medial prefrontal cortex and pedunculopontine nucleus: effects on locomotor activity mediated by nucleus accumbens-ventral pallidal circuitry. Brain Res 1987;412:233-43.
11. Cummings JL. Frontal-subcortical circuits and human behavior. Neurological Review 1993;50:873-80.
12. Vonsattel JP, Difiglia M. Huntington's disease [review]. J Neuropathol Exp Neurol 1998;57:369-84.
13. Middleton FA, Strick PL. Basal ganglia and cerebellar loops: motor and cognitive circuits. Brain Res Rev 2000;31: 236-50.
14. Di Maio L, Squitieri F, Napolitano G, et al. Suicide risk in Huntington's disease. J Med Genet 1993;30:293-5.
15. Cummings JL, Mega M, Gray K, et al. The neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia. Neurology 1994;44:2308-14.
16. The Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993;72:971-83.
17. Folstein MF, Holstein SE, McHugh PR. Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-98.
18. Mattis S. Mental status examination for organic mental syndrome in the elderly patient. In: Bellak L, Karasu TB, eds. Geriatric psychiatry: New York, Grune and Stratton,1976: 77-122.
19. The Huntington Study Group. Unified Huntington's disease rating scale: reliability and consistency. Mov Disord1996;11:136-42.
20. Litvan I, Mega MS, Cummings JL, et al. Neuropsychiatric aspects of progressive supranuclear palsy. Neurology 1996; 47:1184-9.
21. Litvan I, Paulsen JS, Mega MS, et al. Neuropsychiatric assessment of patients with hyperkinetic and hypokinetic movement disorders. Arch Neurol 1998;55:1313-19.
22. Levy ML, Miller BL, Cummings JL, et al. Alzheimer disease and frontotemporal dementias. Behavioral distinctions. Arch Neurol 1996;53:687-90.
23. Kaufer D. Beyond the cholingeric hypothesis: the effect of metrifonate and other cholinesterase inhibitors on neuropsychiatric symptoms in Alzheimer's disease. Dement Geriatr Cogn Disord 1998;2:8-14.
24. Riso LP, Klein DN, Anderson RL, et al. Concordance between patients and informants on the personality disorder examination. Am J Psychiatry 1994;151:568-73.
25. Paulsen JS, Stout JC, Delapena J, et al. Frontal behavioral syndromes in cortical and subcortical dementia. Assessment 1996;3:327-37.
26. Paulsen JS, Butters N, Sadek JR, et al. Distinct cognitive profiles of cortical and subcortical dementia in advanced illness. Neurology 1995;45:951-6.
27. Levy ML, Cummings JL, Fairbanks LA, et al. Apathy is not depression. J Neuropsychiatry Clin Neurosci 1998;10:314-19.
28. Andrew SE, Goldberg YP, Hayden MR. Rethinking genotype and phenotype correlations in polyglutamine expansion disorders. Hum Mol Genet 1997;6:2005-10.
29. Rosenblatt A, Ranen NG, Nance MA, et al. A physician's guide to the management of Huntington's disease. Huntington's Disease Society of America, 1999.
30. Leroi I, Michalon M. Treatment of the psychiatric manifestations of Huntington's disease: a review of the literature [review]. Can J Psychiatry 1998;43:933-40.